{
    "id": "le_l_polnalox__addr2__nal__rxprescriptiveauth_indicator",
    "category": "reproschema:Item",
    "additionalNotesObj": [
        {
            "column": "study",
            "source": "nbdc",
            "value": "Core"
        },
        {
            "column": "domain",
            "source": "nbdc",
            "value": "Linked External Data"
        },
        {
            "column": "sub_domain",
            "source": "nbdc",
            "value": "Policy"
        },
        {
            "column": "source",
            "source": "nbdc",
            "value": "Linked Dataset"
        },
        {
            "column": "name_nda",
            "source": "nbdc",
            "value": "reshist_addr2_nal_Rx_prescriptive_auth"
        },
        {
            "column": "url_table",
            "source": "nbdc",
            "value": "https://docs.abcdstudy.org/latest/documentation/non_imaging/le.html#le_l_polnalox"
        },
        {
            "column": "name_short",
            "source": "nbdc",
            "value": "le_l_polnalox__addr2__nal__rxprescriptiveauth_indicator"
        },
        {
            "column": "name_stata",
            "source": "nbdc",
            "value": "le_l_polnalox_0005"
        },
        {
            "column": "activity",
            "source": "nbdc",
            "value": "le_l_polnalox"
        }
    ],
    "prefLabel": {
        "en": "le_l_polnalox__addr2__nal__rxprescriptiveauth_indicator"
    },
    "question": {
        "en": "Indicates if Naloxone law allowing pharmacists prescriptive authority was effective at date of baseline visit (Address 2) (address 2)"
    },
    "responseOptions": {
        "valueType": [
            "xsd:string"
        ]
    },
    "ui": {
        "inputType": "number"
    },
    "@context": "https://raw.githubusercontent.com/ReproNim/reproschema/main/releases/1.0.0/reproschema"
}